Logo image of XNCR

XENCOR INC (XNCR) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:XNCR - US98401F1057 - Common Stock

16.55 USD
-0.24 (-1.43%)
Last: 12/16/2025, 8:00:03 PM
16.55 USD
0 (0%)
After Hours: 12/16/2025, 8:00:03 PM
Fundamental Rating

3

Taking everything into account, XNCR scores 3 out of 10 in our fundamental rating. XNCR was compared to 529 industry peers in the Biotechnology industry. The financial health of XNCR is average, but there are quite some concerns on its profitability. XNCR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

XNCR had negative earnings in the past year.
XNCR had a negative operating cash flow in the past year.
XNCR had negative earnings in 4 of the past 5 years.
In the past 5 years XNCR reported 4 times negative operating cash flow.
XNCR Yearly Net Income VS EBIT VS OCF VS FCFXNCR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M

1.2 Ratios

XNCR has a better Return On Assets (-15.97%) than 79.21% of its industry peers.
With an excellent Return On Equity value of -22.19%, XNCR belongs to the best of the industry, outperforming 81.47% of the companies in the same industry.
Industry RankSector Rank
ROA -15.97%
ROE -22.19%
ROIC N/A
ROA(3y)-14.92%
ROA(5y)-8.95%
ROE(3y)-20.68%
ROE(5y)-12.58%
ROIC(3y)N/A
ROIC(5y)N/A
XNCR Yearly ROA, ROE, ROICXNCR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

XNCR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
XNCR Yearly Profit, Operating, Gross MarginsXNCR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

More info and screens

5

2. Health

2.1 Basic Checks

XNCR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, XNCR has more shares outstanding
The number of shares outstanding for XNCR has been increased compared to 5 years ago.
The debt/assets ratio for XNCR has been reduced compared to a year ago.
XNCR Yearly Shares OutstandingXNCR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
XNCR Yearly Total Debt VS Total AssetsXNCR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 1.97 indicates that XNCR is not a great score, but indicates only limited risk for bankruptcy at the moment.
XNCR's Altman-Z score of 1.97 is fine compared to the rest of the industry. XNCR outperforms 65.03% of its industry peers.
A Debt/Equity ratio of 0.14 indicates that XNCR is not too dependend on debt financing.
The Debt to Equity ratio of XNCR (0.14) is worse than 64.84% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z 1.97
ROIC/WACCN/A
WACC8.41%
XNCR Yearly LT Debt VS Equity VS FCFXNCR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

2.3 Liquidity

A Current Ratio of 5.99 indicates that XNCR has no problem at all paying its short term obligations.
The Current ratio of XNCR (5.99) is better than 61.81% of its industry peers.
A Quick Ratio of 5.99 indicates that XNCR has no problem at all paying its short term obligations.
XNCR's Quick ratio of 5.99 is fine compared to the rest of the industry. XNCR outperforms 63.33% of its industry peers.
Industry RankSector Rank
Current Ratio 5.99
Quick Ratio 5.99
XNCR Yearly Current Assets VS Current LiabilitesXNCR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

5

3. Growth

3.1 Past

XNCR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 44.69%, which is quite impressive.
Looking at the last year, XNCR shows a very strong growth in Revenue. The Revenue has grown by 96.51%.
The Revenue has been decreasing by -6.75% on average over the past years.
EPS 1Y (TTM)44.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.73%
Revenue 1Y (TTM)96.51%
Revenue growth 3Y-26.22%
Revenue growth 5Y-6.75%
Sales Q2Q%96.07%

3.2 Future

The Earnings Per Share is expected to grow by 10.87% on average over the next years. This is quite good.
XNCR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 39.37% yearly.
EPS Next Y45.95%
EPS Next 2Y10%
EPS Next 3Y10.23%
EPS Next 5Y10.87%
Revenue Next Year113.31%
Revenue Next 2Y42.96%
Revenue Next 3Y30.31%
Revenue Next 5Y39.37%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
XNCR Yearly Revenue VS EstimatesXNCR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M 800M
XNCR Yearly EPS VS EstimatesXNCR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 1 -1 -2 -3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for XNCR. In the last year negative earnings were reported.
Also next year XNCR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XNCR Price Earnings VS Forward Price EarningsXNCR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XNCR Per share dataXNCR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10%
EPS Next 3Y10.23%

More info and screens

0

5. Dividend

5.1 Amount

XNCR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

XENCOR INC

NASDAQ:XNCR (12/16/2025, 8:00:03 PM)

After market: 16.55 0 (0%)

16.55

-0.24 (-1.43%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)02-25 2026-02-25/amc
Inst Owners118.64%
Inst Owner Change-4.73%
Ins Owners1.1%
Ins Owner Change-0.17%
Market Cap1.18B
Revenue(TTM)167.36M
Net Income(TTM)-138.75M
Analysts84
Price Target28.56 (72.57%)
Short Float %12.62%
Short Ratio8.17
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)66.4%
Min EPS beat(2)44.19%
Max EPS beat(2)88.61%
EPS beat(4)3
Avg EPS beat(4)36.93%
Min EPS beat(4)-7.54%
Max EPS beat(4)88.61%
EPS beat(8)4
Avg EPS beat(8)-15.47%
EPS beat(12)7
Avg EPS beat(12)0.09%
EPS beat(16)10
Avg EPS beat(16)90.88%
Revenue beat(2)1
Avg Revenue beat(2)37.58%
Min Revenue beat(2)-24.18%
Max Revenue beat(2)99.34%
Revenue beat(4)3
Avg Revenue beat(4)74.2%
Min Revenue beat(4)-24.18%
Max Revenue beat(4)165.74%
Revenue beat(8)3
Avg Revenue beat(8)22.23%
Revenue beat(12)6
Avg Revenue beat(12)26.44%
Revenue beat(16)9
Avg Revenue beat(16)40.88%
PT rev (1m)4.87%
PT rev (3m)14.03%
EPS NQ rev (1m)9.74%
EPS NQ rev (3m)19.24%
EPS NY rev (1m)26.31%
EPS NY rev (3m)28.98%
Revenue NQ rev (1m)8.28%
Revenue NQ rev (3m)4.83%
Revenue NY rev (1m)-2.68%
Revenue NY rev (3m)-3.65%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 7.06
P/FCF N/A
P/OCF N/A
P/B 1.89
P/tB 1.92
EV/EBITDA N/A
EPS(TTM)-1.77
EYN/A
EPS(NY)-2.77
Fwd EYN/A
FCF(TTM)-2.01
FCFYN/A
OCF(TTM)-1.95
OCFYN/A
SpS2.34
BVpS8.76
TBVpS8.62
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -15.97%
ROE -22.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-14.92%
ROA(5y)-8.95%
ROE(3y)-20.68%
ROE(5y)-12.58%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 42.94%
Cap/Sales 2.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.99
Quick Ratio 5.99
Altman-Z 1.97
F-Score3
WACC8.41%
ROIC/WACCN/A
Cap/Depr(3y)252.19%
Cap/Depr(5y)241.55%
Cap/Sales(3y)15.72%
Cap/Sales(5y)12.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.73%
EPS Next Y45.95%
EPS Next 2Y10%
EPS Next 3Y10.23%
EPS Next 5Y10.87%
Revenue 1Y (TTM)96.51%
Revenue growth 3Y-26.22%
Revenue growth 5Y-6.75%
Sales Q2Q%96.07%
Revenue Next Year113.31%
Revenue Next 2Y42.96%
Revenue Next 3Y30.31%
Revenue Next 5Y39.37%
EBIT growth 1Y44.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year31.32%
EBIT Next 3Y19.9%
EBIT Next 5Y10.61%
FCF growth 1Y4.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-15.34%
OCF growth 3YN/A
OCF growth 5YN/A

XENCOR INC / XNCR FAQ

Can you provide the ChartMill fundamental rating for XENCOR INC?

ChartMill assigns a fundamental rating of 3 / 10 to XNCR.


What is the valuation status for XNCR stock?

ChartMill assigns a valuation rating of 0 / 10 to XENCOR INC (XNCR). This can be considered as Overvalued.


Can you provide the profitability details for XENCOR INC?

XENCOR INC (XNCR) has a profitability rating of 1 / 10.